Assessment of Bone Metabolism Alterations in Transfusion-dependent Beta-thalassemia Major: An Observational Study
- PMID: 32815882
- DOI: 10.1097/MPH.0000000000001911
Assessment of Bone Metabolism Alterations in Transfusion-dependent Beta-thalassemia Major: An Observational Study
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5:11.
-
- Haidar R, Musallam KM, Taher AT. Bone disease and skeletal complications in patients with b thalassemia major. Bone. 2011;48:425–432.
-
- Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br J Haematol. 2014;127:127–139.
-
- Forni GL, Perrotta S, Giusti A, et al. Neridronate improves bone mineral density and reduces back pain in beta-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label-study. Br J Haematol. 2012;158:274–282.
-
- Baldan A, Giusti A, Bosi C, et al. Klotho, a new marker for osteoporosis and muscle strength in b-thalassemia major. Blood Cells Mol Dis. 2015;55:396–401.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources